Why the McMillan Shakespeare (ASX:MMS) share price has slipped today

The McMillan Shakespeare (ASX MMS) share price has slipped 2.46% following the release of its half-year results. Here's the low down.

| More on:
ASX share price slide represented by investor slipping on banana skin

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The McMillan Shakespeare Limited (ASX: MMS) share price is falling after the financial products and services firm put out its half-year results today.

At the time of writing, the McMillan Shakespeare share price is trading at $12.68, down 2.46%. Let's look at the company's performance for the six months ended 31 December 2020 (1H21).

Key financial updates

McMillan Shakespeare reported an 8.4% loss in revenues for a 1H21 total of $247.6 million.

Earnings before interest, tax, depreciation and amortisation (EBITDA) was up 19.1% from $57.2 million in 1H20 to $68.2 million in 1H21.

Net profit after taxes (NPAT) tumbled 25% to $25.5 million in 1H21 compared to $34 million in 1H20. Underlying net profit after taxes (UNPATA) was 13% higher totalling $42.7 million for 1H21.

The firm's free cash flow pumped 23.4%, hitting $42.2 million for 1H21.

Basic earnings per share (EPS) was 42.1 cents per share, a notch up from the 1H20 EPS of 41.6 cents per share.

McMillan Shakespeare declared a fully franked dividend of 30.2 cents per share for the period.

Half-year insight and outlook

The company advised that it continued to manage "extremely challenging trading conditions" during 1H21 brought about by the coronavirus pandemic.

Such conditions included lockdown restrictions in Australia, New Zealand and the UK that negatively impacted sales activities.

The federal government's JobKeeper program provided the company with $7.3 million (after tax) to retain staff during the COVID-19 economic downturn.

Looking ahead, McMillan Shakespeare expects improved conditions in the broader motor industry.

It advised that it expected COVID-19 would continue to impact operations, business and consumer activity. The company also said there was potential for further disruption.

McMillan Shakespeare predicted the business outlook for 2H21 performance to be similar to that of 1H21, excluding the JobKeeper payment.

McMillan Shakespeare share price snapshot

Despite the challenges, the McMillan Shakespeare share price has gained 8.06% over the past 12 months.

The company's market capitalisation is $975.1 million, and there are presently 76.8 million shares outstanding.

Motley Fool contributor Gretchen Kennedy owns shares of McMillan Shakespeare Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »